Latest News
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock?
While the biggest driver of growth for Amazon (NASDAQ: AMZN) has been coming from its cloud computing division, Amazon Web Services (AWS), the company is not just sitting still when it comes to other areas of its business. It recently set its...
Hims & Hers Stock Is Down 30% This Week: Here's What Happened
Hims & Hers has given back recent gains, but don't overlook the company's massive growth.
Should You Buy Hims & Hers Stock on the Dip?
Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach.
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.66%. Stocks retreated on Thursday, with the S&P 500, the Dow Jones Industrials, and the...
Another Peak for TSX
Canada's main stock index touched a record high on Thursday, helped by energy stocks, while investors ...
Up 298% in a Year, Is Hims & Hers Health Still a Buy?
The healthcare company is on fire, and it's still cheap by many measures.
Hims & Hers, Payoneer, and Astera Labs lead Q3 earnings with standout revenue growth, forecast upgrades, and strategic wins—stocks to watch for growth potential
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Hims & Hers strong performance involves much more than just GLP-1 drugs.
Missed Out on Eli Lilly? Buy This Amazing Growth Stock Instead
The company expects to enjoy many GLP-1 tailwinds in 2025.
According to analysts, even after a 6% rally on the morning of the earnings announcement, Hims & Hers stock might still be a buy today.
Could This Magnificent Pharma Stock 10x in the Next 5 Years?
Disrupting pharmacies is just the start for Hims & Hers.
Despite the stock market trading at new all-time highs, institutions still find enough reason to buy more enormous stakes in three stocks.
Hims & Hers Health Inc (HIMS) has been a standout performer in the stock market, experiencing an impressive 275% surge over the last 12 months. This remarkable gain positions the company at the forefront of growth in the Household & Personal Products sector. Let’s explore the reasons behind this growth...
Hims & Hers Stock Dropped: Here's What You Need to Know
The GLP-1 drama continues at Hims & Hers.
Why Hims & Hers' Incredible Growth Will Continue
GLP-1s get all the attention, but Hims & Hers' core business is where the rocket growth is.
Where Does Hims & Hers Stock Go From Here?
Is Hims & Hers in trouble since the FDA put a time clock on some GLP-1s, or is the future still bright?
2 Incredibly Cheap Growth Stocks to Buy Right Now
Look beyond the stock price at the business when shares are volatile.
2 No-Brainer Growth Stocks to Buy With $500 Right Now
Consistently investing even moderate sums can grow your portfolio with time.
What Is Going On With Hims & Hers Stock?
Big GLP-1 news could have an impact.
Three stocks reported a surge in call option buying recently, showing investors that there could be a path to more upside potential, analysts agree
There is now a new reason to look into Hims & Hers stock for additional upside, including the new addition to the S&P 600 index alongside double-digit growth.
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?
Growth for its GLP-1 weight loss drugs continues to be robust.
Massive News for Hims & Hers Stock: The Truth About Today's Move
Hims & Hers may not be hurt by GLP-1 news the way investors think.
2 Winning Growth Stocks That Are Screaming Buys Right Now
These top stocks are on a winning streak and have the businesses to keep it going.
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down by -0.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.05%. Stocks fell moderately on Thursday, with the Dow Jones Industrials dropping...